FGF19 and hepatocellular carcinoma: We compared the FGF19 concentrations in the control, T2DM, HCC, and T2DM-HCC groups and found that they were high in both T2DM-HCC and HCC patients, but low in T2DM patients (Table 1 and Figure 1).